Impact of a Telenursing Service on Satisfaction and Health Outcomes of Children With Inflammatory Rheumatic Diseases
|ClinicalTrials.gov Identifier: NCT01511341|
Recruitment Status : Completed
First Posted : January 18, 2012
Last Update Posted : February 4, 2015
Paediatric rheumatisms represent a large group of inflammatory and non-inflammatory diseases of the locomotion system. The annual rate incidence of children diagnosed with rheumatic disease in Switzerland (canton of Vaud) is 56.8 for 100'000 children. These children experience a chronic course of the disease impacting on their quality of life and family functioning. Their medical treatment is significant and may last for life. Caring for these children involves a multidisciplinary approach. Control of the disease and management of the symptoms becomes of foremost importance to minimise disability and pain. In addition to medical care, the supporting role of nurses in the care of children with rheumatic diseases and their family aims to limit the potential for further deformity, disability, and psychological complications. In particular, they play a key role in supporting the specialist team caring for patients with rheumatism disease, recognising poor disease control and the need for changes in treatment, providing a resource to patients on treatment options and how to access additional support and advice, and identifying best practice to achieve optimal outcomes for the patients and their family. Nurses also ensure the link between medical practitioner, other health providers, and family, thus play a key role in the follow-up care of the child and its family. Follow-up of children and their family can be ensured by regular telephone consultation (telenursing) made by experienced nurse specialists in rheumatology. However, the effectiveness of telenursing remains to be proven in children with chronic rheumatic diseases. The aim of this study is, therefore, to evaluate the effect of a telephone nursing intervention on the outcomes of family and children with rheumatism chronic disease.
This randomised crossover, experimental longitudinal study will be carried out in the outpatient clinic of paediatric rheumatology of a tertiary referral hospital in canton of Vaud. The population will consist of children newly diagnosed with inflammatory rheumatologic diseases and one of their parent. The nurse-led intervention will consist of providing a monthly telephone call by a qualified and experienced nurse specialist in paediatric rheumatology and TN to ensure follow-up of the children and their family. The intervention will focus on providing affective support, health information, and aid to making decision.
|Condition or disease||Intervention/treatment||Phase|
|Inflammatory Rheumatism||Behavioral: Telenursing||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||55 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Single (Outcomes Assessor)|
|Primary Purpose:||Supportive Care|
|Official Title:||Impact of a Telenursing Service on Satisfaction and Health Outcomes of Children With Inflammatory Rheumatic Diseases and Their Family: a Crossover Trial|
|Study Start Date :||August 2011|
|Actual Primary Completion Date :||September 2014|
|Actual Study Completion Date :||September 2014|
The nurse-led intervention will consist of providing a monthly telephone call by a qualified and experienced nurse specialist in paediatric rheumatology and TN to ensure follow-up of the children and their family. The intervention will focus on providing affective support, health information, and aid to making decision.
No Intervention: Standard practice
Group receive the standard practice, without telephone nursing intervention.
- Satisfaction [ Time Frame: 2 years ]Mixed methods, with Client Satisfaction Questionnaire (CSQ-8), and semi-structured interview
- Telenursing service utilisation [ Time Frame: 2 years ]Telenursing service utilisation will be recorded in terms of number, time and duration of calls, who made the call, the nature of the call, decision made, description of the plan for action, and follow-through of the advice.
- Adherence to therapeutic regimen [ Time Frame: 2 years ]Parent Adherence Report Questionnaire (PARQ) and Child Adherence Report Questionnaire (CARQ)
- Cost effectiveness [ Time Frame: 2 years ]Cost will be descriptive in nature and be estimated by calculating the cost related to the time for the use of the service by a qualified nurse versus what the parents would have done if the service was not avalaible.
- Clinical status (disease activity, QOL) [ Time Frame: 2 years ]Juvenile Arthritis Disease Activity Score (JADAS) and Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01511341
|University Hospital of Vaud - Department of Pediatrics|
|Lausanne, Vaud, Switzerland, 1011|
|Principal Investigator:||Anne-Sylvie Ramelet, PhD||Institut universitaire de formation et de recherche en soins-IUFRS|